Literature DB >> 12942464

Acquired (non-Wilsonian) hepatocerebral degeneration: complex management decisions.

Eelco F m Wijdicks1, Russell H Wiesner.   

Abstract

Portal systemic encephalopathy, in its many guises, can be reversible after medical management or liver transplantation. It is much less certain whether patients with a longstanding neurodegenerative syndrome (known in the medical vernacular as acquired hepatocerebral degeneration) can improve. Impressive neuroimaging abnormalities have been reported in this entity.(1) However, the combination of a severe disabling neurologic deficit and widespread magnetic resonance abnormalities tempers the enthusiasm of transplant surgeons to proceed with liver transplantation. In our liver transplantation program, we were recently confronted with such a case, and present herein not only the characteristic magnetic resonance imaging findings but also some of the dilemmas of management.

Entities:  

Mesh:

Year:  2003        PMID: 12942464     DOI: 10.1053/jlts.2003.50107

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  9 in total

Review 1.  Acquired hepatocerebral degeneration.

Authors:  Joseph Ferrara; Joseph Jankovic
Journal:  J Neurol       Date:  2009-02-17       Impact factor: 4.849

Review 2.  Encephalopathy in Wilson disease: copper toxicity or liver failure?

Authors:  Peter Ferenci; Tomasz Litwin; Joanna Seniow; Anna Czlonkowska
Journal:  J Clin Exp Hepatol       Date:  2014-09-22

3.  Embolization of splenorenal shunt associated to portal vein thrombosis and hepatic encephalopathy.

Authors:  Letícia de Campos Franzoni; Fábio Cardoso de Carvalho; Rafael Gomes de Almeida Garzon; Fábio da Silva Yamashiro; Laís Augusti; Lívia Alves Amaral Santos; Mariana de Souza Dorna; Júlio Pinheiro Baima; Talles Bazeia Lima; Carlos Antonio Caramori; Giovanni Faria Silva; Fernando Gomes Romeiro
Journal:  World J Gastroenterol       Date:  2014-11-14       Impact factor: 5.742

4.  Chronic acquired hepatocerebral degeneration: effects of liver transplantation on neurological manifestations.

Authors:  A Stracciari; E Baldin; L Cretella; L Delaj; R D'Alessandro; M Guarino
Journal:  Neurol Sci       Date:  2011-02-17       Impact factor: 3.307

5.  Liver transplantation significantly improves global functioning and cerebral processing.

Authors:  Vishwadeep Ahluwalia; James B Wade; Melanie B White; HoChong S Gilles; Douglas M Heuman; Michael Fuchs; Edith A Gavis; Andrew Fagan; Felicia Tinsley; Dinesh Ganapathy; Leroy R Thacker; Richard K Sterling; R Todd Stravitz; Puneet Puri; Arun J Sanyal; Muhammad S Siddiqui; Scott Matherly; Velimir Luketic; Joel Steinberg; F Gerard Moeller; Jasmohan S Bajaj
Journal:  Liver Transpl       Date:  2016-10       Impact factor: 5.799

6.  Cognitive functioning in chronic acquired hepatocerebral degeneration.

Authors:  Andrea Stracciari; Katia Mattarozzi; Roberto D'Alessandro; Elisa Baldin; Maria Guarino
Journal:  Metab Brain Dis       Date:  2008-04-24       Impact factor: 3.584

7.  Chronic acquired hepatocerebral degeneration presenting with Meige's syndrome and behavioral symptoms fully reversed by liver transplantation.

Authors:  Andrea Stracciari; Luca Spinardi; Maria Guarino
Journal:  Neurol Sci       Date:  2021-07-19       Impact factor: 3.307

8.  Acquired hepatocerebral degeneration.

Authors:  Pushpendra Nath Renjen; Laxmi Khanna; Ruchi Rastogi; Nadeem Israr Khan
Journal:  BMJ Case Rep       Date:  2013-06-18

9.  Erythromycin versus neomycin in the treatment of hepatic encephalopathy in cirrhosis: a randomized double-blind study.

Authors:  Fernando Gomes Romeiro; Fabio da Silva Yamashiro; Madileine Francely Américo; Luciana Aparecida Corá; Giovanni Faria Silva; José Ricardo de Arruda Miranda; Carlos Antonio Caramori
Journal:  BMC Gastroenterol       Date:  2013-01-16       Impact factor: 3.067

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.